CHEMED CORP
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.5B | $2.4B | $2.3B | $2.1B | $2.1B |
| Operating income | $338.2M | $366.5M | $340.6M | $343.5M | $343.0M |
| Operating expenses | $2.2B | $2.1B | $1.9B | $1.8B | — |
| Cost of revenue | $1.7B | $1.6B | $1.5B | $1.4B | $1.4B |
| Cash from operations | $388.3M | $417.5M | $330.3M | $309.9M | $308.6M |
| Capital expenditure | $62.8M | $49.5M | $56.9M | $57.3M | $58.7M |
| Free cash flow | $325.5M | $368.0M | $273.4M | $252.6M | $249.9M |
| Share repurchases | $431.5M | $361.4M | $67.7M | $114.5M | $576.0M |
| Total assets | $1.5B | $1.7B | $1.7B | $1.4B | $1.3B |
| Total liabilities | $558.8M | $549.6M | $560.2M | $643.3M | $719.5M |
Shares outstanding 13.3M · Free float 95.1%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.